PMC10288294_01
PMC10288294_02
Growth chart of the patient. The initial daily dose of KCl and NaCl was 1.5 g and 1.0
g, respectively. Superimposed is an electrocardiogram recorded at admission, showing
tachycardia with a heart rate of 135/min and T-wave flattening.
cpe-32-155-g001.jpg
PMC10288294_02_cpe-32-155-g001.jpg
fig_001
One month later, her general practitioner pointed out a 5.6% decrease in her body weight (Fig. 1) and referred her to us for scrutiny of failure to thrive. T-wave flattening (Fig. 1), and echocardiography revealed adequate cardiac function. The renal and urinary tract morphologies were unremarkable on ultrasonography. Twelve months after the cessation of therapy, her height was the mean for age, with a BMI +0.88 SD (Fig. 1).